Skip to contentC
Chemed Corp
C
CHEChemed Corp Q3 2023 · 10-Q
Revenue$333.73M$333.73M+12.5% vs Q3 2022 Net Income$74.96M$74.96M+31.8% vs Q3 2022 EPS Diluted$4.93$4.93+30.4% vs Q3 2022 Operating Income$86,850,000+7.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$17,272,000−55.2% Margins · derivedOperating margin26.0%−1.2 pt vs Q3 2022
Net margin22.5%+3.3 pt vs Q3 2022
ended Sep 30, 2023 · filed Oct 27, 2023 · 27 d after period end